How to write a world-class paper: a formula for success?
UMCG, Nov 2014
Peter de Jonge Interdisciplinary Center Psychopathology and Emotion RegulationUMCG University of [email protected]
Prognostic association of depression following myocardial
infarction with mortality and cardiovascular events: A meta-
analysis. Van Melle JP, de Jonge, P, Spijkerman TA,
Tijssen JGP, Ormel J, van Veldhuisen DJ, van den Brink RHS,
van den Berg MP. Psychosom Med 2004.
As of May/June 2014, this highly cited paper received enough citations to place it in the top 1% of the academic field of Psychiatry/Psychology based on a highly cited threshold for the field and publication year.
Data from Essential Science Indicators ℠
Lesson 1: When it is possible to do the study better than
you intended, do it better.
Lesson 2: don’t be afraid to build on your good name / never change a winning team
Prognostic association of depression following
myocardial infarction with mortality and cardiovascular
events: a meta-analysis of 25 years of research. Meijer A
, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge, P.
Gen Hosp Psych 2011
Lesson 2: don’t be afraid to build on your good name / never change a winning team
Prognostic association of depression following
myocardial infarction with mortality and cardiovascular
events: a meta-analysis of 25 years of research. Meijer A
, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge, P.
Gen Hosp Psych 2011
•Times Cited: 73
Prognostic Association of Anxiety Post Myocardial Infarction With Mortality and New Cardiac Events: A Meta-Analysis. Roest AM, Martens EJ, Denollet J, de Jonge P. Psychosom Med 2010.
Lesson 3: dedicate your efforts to find an appropriate journal
where your paper will actually be read an referred to.
What is more important: a high-impact journal or being
cited?
van der Werf SY, Kaptein KI, de Jonge P, Korf J.
Major depressive episodes and random mood. JAMA-Psych
2006
Times Cited: 9
Lesson 4: Look for (external) excellent partners
Average Citations per Item : 29.19
h-index : 47
Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart DiseaseWhooley MA, de Jonge P, Vittinghoff E, et al. JAMA 2008
As of May/June 2014, this highly cited paper received
enough citations to place it in the top 1% of the
academic field of Clinical Medicine based on a highly
cited threshold for the field and publication year
Lesson 5: Sometimes you just know it is going to be good.
Depression Screening and Patient Outcomes in Cardiovascular Care A Systematic Review
. Thombs BD, de Jonge P, Coyne JC, et al. JAMA 2008.
Times Cited: 208
Lesson 6: And sometimes you don’t
Response sets in self-report data and their associations with
personality traits. De Jonge P, Slaets, JPJ. Eur J Psych 2005.
Times Cited: 8
Lessons
Lesson 1: When it is possible to do the study better than you
intended, do it better.
Lesson 2: Don’t be afraid to build on your good name / never
change a winning team
Lesson 3: Dedicate your efforts to find an appropriate journal
where your paper will actually be read an referred to
Lesson 4: Look for (external) excellent partners
Lesson 5: Sometimes you just know it is going to be good
Lesson 6: And sometimes you don’t
Prospective validation
Turner EH, et al. Selective publication of antidepressant trials
and its influence on apparent efficacy (in depression). NEJM
2008
Times Cited: 793
How about anxiety?
A good idea…
2011: Dutch Brain Foundation
2012: Annelieke Roest to Oregon USA
2013: Hard work / little time
2014: June, manuscript submitted to JAMA
Efficacy of SSRIs/SNRIs
Roest AM, Jonge P, Williams CD, de Vries YA, Schoevers RA, Turner EH.
GAD 0.35 (0.28-0.43)
PD 0.35 (0.25-0.45)
SAD 0.42 (0.35-0.49)
PTSD 0.32 (0.14-0.50)
OCD 0.41 (0.30-0.51)
GAD 0.32 (0.25-0.39)
PD 0.28 (0.19-0.36)
SAD 0.39 (0.30-0.49)
PTSD 0.27 (0.11-0.44)
OCD 0.39 (0.30-0.49)
Small, overestimated and
Real efficacy
MDD 0.32 (0.27-0.35) (turner et al 2008)
Apparent efficacy
MDD 0.41 (0.36-0.45)
interchangeable across disorders
RE: Reporting bias in clinical trials investigating the efficacy of second generation antidepressants
in the treatment of anxiety disorders
Dear Dr. Roest: August 10, 2014
Thank you for submitting your manuscript to JAMA. Based on
our editorial evaluation and the comments of our peer
reviewers, I regret to inform you that we will not accept your
manuscript for publication. However, as you are aware, the
JAMA Network allows submitted manuscripts to have more
than one opportunity for evaluation for publication. This
network includes JAMA Psychiatry...
RE: Reporting bias in clinical trials investigating the efficacy of second generation antidepressants
in the treatment of anxiety disorders
Dear Dr. Roest: September 30, 2014
We have completed our review of your manuscript and are
considering accepting it for publication in JAMA Psychiatry,
provided that it is suitably revised to address the criticisms
and suggestions of the reviewers……
RE: Reporting bias in clinical trials investigating the efficacy of second generation antidepressants
in the treatment of anxiety disorders
Dear Dr. Roest: November 4, 2014
Based on our evaluation, I regret to inform you that we will
not pursue the manuscript you have submitted for publication.
We are a journal of general psychiatric research, and your
paper, in our view, would be more appropriate for a
subspecialty journal such as Am J Geriatric Psychiatry.
=>I hope that you are willing to check whether something
went wrong in the editorial process.
From: Coyle, Joseph T. [[email protected]]
Sent: woensdag 5 november 2014 21:26
Subject: RE: PSY14-0799R Wrong Decision Letter??
Sorry. An electronic mistake. We will send the revision out for
review by previous reviewers.
RE: Reporting bias in clinical trials investigating the efficacy of second generation antidepressants
in the treatment of anxiety disorders
Is it going to be a world-class paper?
Lessons
Lesson 1: When it is possible to do the study better than you
intended, do it better
Lesson 2: Don’t be afraid to build on your good name / never
change a winning team
Lesson 3: Dedicate your efforts to find an appropriate journal
where your paper will actually be read an referred to
Lesson 4: Look for excellent (internal and external) partners
Lesson 5: Sometimes you just know it is going to be good
Lesson 6: And sometimes you don’t
Lesson 7: You can only write a world-class paper when you
quit writing non world-class papers
Lesson 8: Be a judge of your own work
Thank you for your attention